OrderlyMeds · Compounded semaglutide (injection)

Editorial tradeoffs

Useful for comparing: Cash-pay readers who want the lowest published first-month compounded-GLP-1 price and will plan around the introductory rate doubling after the promotional period

Limitations in the record

• Reported introductory monthly-equivalent advertisements, not verified first-month debits: compounded tirzepatide starter $149/mo, $299 total for 2 months; compounded semaglutide starter $74/mo, $149 total for 2 months. Pricing labels these Save 50% and new-customer-only. The homepage says starter patients must begin at the lowest available dose and pay upfront in full. Transfer/new-customer 2-month special offer (Save 25%): tirzepatide $224/mo, $449 for 2 months; semaglutide $112/mo, $224 for 2 months. Preserve the provider's displayed rounding rather than multiplying the monthly-equivalent headline into a different total. Advertised brand month-to-month plans are Wegovy $1,839/month and Zepbound $1,498/month; no separate brand introductory discount is published in the captured pricing/product pages. Exact individual first charge including any applicable taxes is UNKNOWN; no checkout or debit was observed. Reported monthly plans: Wegovy (GLP-1 pen) $1,839/month; Zepbound (GLP-1/GIP pen) $1,498/month; compounded semaglutide injections $149/month; compounded tirzepatide injections $299/month. Compounded product pages label standard monthly prices for current GLP-1 users and returning customers. Discounted new-customer starter tiers: semaglutide $74/mo ($149 total/2 months) and tirzepatide $149/mo ($299 total/2 months), Save 50%, lowest-dose starter and upfront full payment conditions. New-customer transfer tiers: semaglutide $112/mo ($224 total/2 months) and tirzepatide $224/mo ($449 total/2 months), Save 25%. These are advertised monthly rates/monthly equivalents and published plan totals, not verified exact first or renewal debits. FAQ says customers are charged only when they request a refill, with no subscription required; prices are not guaranteed for future orders. FAQ also ambiguously extends the $74/$149 introductory figures to month-to-month purchases, conflicting with explicit $149/$299 standard prices on pricing and product pages; retain this discrepancy rather than lowering standard prices. Provider reports consultations, medication if prescribed, syringes and shipping included, no membership/setup fees. Terms last updated September 24, 2024 reserve price changes and applicable taxes at checkout. Individual all-in total remains UNKNOWN.
• Reported monthly plans: Wegovy (GLP-1 pen) $1,839/month; Zepbound (GLP-1/GIP pen) $1,498/month; compounded semaglutide injections $149/month; compounded tirzepatide injections $299/month. Compounded product pages label standard monthly prices for current GLP-1 users and returning customers. Discounted new-customer starter tiers: semaglutide $74/mo ($149 total/2 months) and tirzepatide $149/mo ($299 total/2 months), Save 50%, lowest-dose starter and upfront full payment conditions. New-customer transfer tiers: semaglutide $112/mo ($224 total/2 months) and tirzepatide $224/mo ($449 total/2 months), Save 25%. These are advertised monthly rates/monthly equivalents and published plan totals, not verified exact first or renewal debits. FAQ says customers are charged only when they request a refill, with no subscription required; prices are not guaranteed for future orders. FAQ also ambiguously extends the $74/$149 introductory figures to month-to-month purchases, conflicting with explicit $149/$299 standard prices on pricing and product pages; retain this discrepancy rather than lowering standard prices. Provider reports consultations, medication if prescribed, syringes and shipping included, no membership/setup fees. Terms last updated September 24, 2024 reserve price changes and applicable taxes at checkout. Individual all-in total remains UNKNOWN.
• Delivery is stated at about 8-10 business days and orders cannot be expedited
• The LegitScript certification is the provider's own claim; we did not query the public registry in this pass
• Compounded drugs are not FDA approved

Feature evidence and unknowns

Not stated

Compounded GLP-1s dispensed by 503A compounding pharmacies; brand-name pens are the FDA-approved products.